new arga
new arga
  • Home
  • Team
  • Technology
  • Energy Delivery
  • Physicians
  • News
  • Investors
  • Contact
  • More
    • Home
    • Team
    • Technology
    • Energy Delivery
    • Physicians
    • News
    • Investors
    • Contact

  • Home
  • Team
  • Technology
  • Energy Delivery
  • Physicians
  • News
  • Investors
  • Contact

Initial Results of the BURST-AF Study

Sine Wave Electroporation in Patients with Atrial Fibrillation – Initial Results of the BURST-AF Study


Results from the BURST-AF clinical trial of #ArgaMedtech's Coherent Sine Burst pulsed field ablation system were presented today at #HRS2025 by principal investigator #anteanic and simultaneously published online in Heart Rhythm Journal.


Highlights from the study included 90 patients enrolled with both paroxysmal and persistent AF. Remapping was performed at 60–120 days post-procedure in 88 patients.  


Key points:

  • Single catheter solution (stylet-configurable, circular, linear and focal ablation) utilizing Sine Wave Pulsed Field Ablation for paroxysmal and persistent atrial fibrillation. 
  • Lesion durability at 3 months is >98% when using optimized energy delivery and workflow recommendations.
  • Outcome data at 6-months is promising, with 94.7% (PAF) and 90% (PersistentAF) patients free from recurrent atrial arrhythmias with or without anti-arrhythmic drug therapy. 


View the full manuscript at https://www.heartrhythmjournal.com/article/S1547-5271(25)02390-2/fulltext

Ante Anic, MD

Copyright © 2024 Argá Medtech SA - All Rights Reserved.

  • Home
  • Team
  • Technology
  • Energy Delivery
  • Physicians
  • News
  • Investors
  • Contact

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept